Raymond K Anton (Raymond Anton, Raymond F Anton, Ray Anton)

ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 20

Top Venues

Alcoholism, clinical and experimental research

Alcohol, clinical & experimental research

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology

The pharmacogenomics journal

Medical University of South Carolina

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of South Carolina

United States

Professor of Psychiatry :: Department of Psychiatry and Behavioral Sciences

Medical University of South Carolina

United States

Scientific Director for Clinical Research :: Alcohol Research Center

Medical University of South Carolina

United States

Distinguished University Professor

Medical University of South Carolina

United States

Director of Clinical-Neurobiology Lab :: Institute of Psychiatry

Publications

Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research 48 (2) (2024)
William Mellick, Lisa McTeague, Sara Hix, Raymond K Anton, James J Prisciandaro
Blunted reward-related activation to food scenes distinguishes individuals with alcohol use disorder in a pilot case-control fMRI pilot study. Alcohol, clinical & experimental research (2024)
Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research 48 (2) (2024)
Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research (2023)
Joseph P Schacht, Matthew Kubicki, Raymond K Anton
A randomized trial of the effects of COMT inhibition on subjective response to alcohol: Moderation by baseline COMT activity and mediation of alcohol self-administration. Alcohol, clinical & experimental research 48 (1) (2023)
Felicia R Tuchman, Kevin A Hallgren, Dylan K Richards, Arnie Aldridge, Raymond K Anton, Henri-Jean Aubin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Katie A Witkiewitz
Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder. Alcohol, clinical & experimental research (2023)
Joseph P Schacht, null Yeongbin Im, Michaela Hoffman, Konstantin E Voronin, Sarah W Book, Raymond K Anton
Effects of pharmacological and genetic regulation of COMT activity in alcohol use disorder: a randomized, placebo-controlled trial of tolcapone. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 47 (11) (2022)
Joseph P Schacht, Michaela Hoffman, Brian H Chen, Raymond K Anton
Epigenetic moderators of naltrexone efficacy in reducing heavy drinking in Alcohol Use Disorder: a randomized trial. The pharmacogenomics journal (2021)
Joanna M Biernacka, Brandon J Coombes, Anthony Batzler, Ada Man-Choi Ho, Jennifer R Geske, Joseph Frank, Colin A Hodgkinson, Michelle Skime, Colin Colby, Lea Zillich, Sofia Pozsonyiova, Ming-Fen Ho, Falk Kiefer, Marcella D C Rietschel, Richard Weinshilboum, Stephanie S O'Malley, Karl F Mann, Raymond K Anton, David Goldman, Victor M Karpyak
Genetic contributions to alcohol use disorder treatment outcomes: a genome-wide pharmacogenomics study. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology 46 (12) (2021)
Raymond K Anton, Konstantin E Voronin, Sarah W Book, Patricia K Latham, Patrick K Randall, Willam Bailey Glen, Michaela Hoffman, Joseph P Schacht
Opioid and Dopamine Genes Interact to Predict Naltrexone Response in a Randomized Alcohol Use Disorder Clinical Trial. Alcoholism, clinical and experimental research 44 (10) (2020)
Justin R Knox, Jennifer Scodes, Katie A Witkiewitz, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Melanie Wall, Raymond K Anton, Deborah S Hasin, null null
Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease. Alcoholism, clinical and experimental research 44 (8) (2020)
Katie A Witkiewitz, Daniel E Falk, Raye Z Litten, Deborah S Hasin, Henry R Kranzler, Karl F Mann, Stephanie S O'Malley, Raymond K Anton
Maintenance of World Health Organization Risk Drinking Level Reductions and Posttreatment Functioning Following a Large Alcohol Use Disorder Clinical Trial. Alcoholism, clinical and experimental research 43 (5) (2019)
Raymond K Anton, Katie A Witkiewitz, Daniel E Falk, Raye Litten, Deborah Hasin, Karl F Mann, Stephanie O'Malley, null null
Response to Dr. Mark Litt's Commentary. Alcoholism, clinical and experimental research 43 (10) (2019)
James J Prisciandaro, Joseph P Schacht, Andrew P Prescot, Perry F Renshaw, Truman R Brown, Raymond K Anton
Brain Glutamate, GABA, and Glutamine Levels and Associations with Recent Drinking in Treatment-Naïve Individuals with Alcohol Use Disorder Versus Light Drinkers. Alcoholism, clinical and experimental research 43 (2) (2019)
Justin Knox, Melanie Wall, Katie A Witkiewitz, Henry R Kranzler, Daniel E Falk, Raye Litten, Karl F Mann, Stephanie S O'Malley, Jennifer Scodes, Raymond K Anton, Deborah S Hasin, null null
Reduction in Nonabstinent WHO Drinking Risk Levels and Change in Risk for Liver Disease and Positive AUDIT-C Scores: Prospective 3-Year Follow-Up Results in the U.S. General Population. Alcoholism, clinical and experimental research 42 (11) (2018)
Katie A Witkiewitz, Henry R Kranzler, Kevin A Hallgren, Stephanie S O'Malley, Daniel E Falk, Raye Z Litten, Deborah S Hasin, Karl F Mann, Raymond K Anton
Drinking Risk Level Reductions Associated with Improvements in Physical Health and Quality of Life Among Individuals with Alcohol Use Disorder. Alcoholism, clinical and experimental research 42 (12) (2018)
Raymond K Anton, Patricia K Latham, Konstantin E Voronin, Patrick K Randall, Sarah W Book, Michaela Hoffman, Joseph P Schacht
Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence. Alcoholism, clinical and experimental research 42 (4) (2018)
Raymond K Anton, Joseph P Schacht, Konstantin E Voronin, Patrick K Randall
Aripiprazole Suppression of Drinking in a Clinical Laboratory Paradigm: Influence of Impulsivity and Self-Control. Alcoholism, clinical and experimental research 41 (7) (2017)
Katie A Witkiewitz, Adam D Wilson, Matthew R Pearson, Kevin A Hallgren, Daniel E Falk, Raye Z Litten, Henry R Kranzler, Karl F Mann, Deborah S Hasin, Stephanie S O'Malley, Raymond K Anton
Temporal Stability of Heavy Drinking Days and Drinking Reductions Among Heavy Drinkers in the COMBINE Study. Alcoholism, clinical and experimental research 41 (5) (2017)
Raye Z Litten, Daniel E Falk, Stephanie S O'Malley, Katie A Witkiewitz, Karl F Mann, Raymond K Anton
Letter to Editor in Response to Johnson's Commentary (2017) on the Witkiewitz and Colleagues (2017) Article. Alcoholism, clinical and experimental research 41 (7) (2017)

Raymond K Anton.css-eqlu8i{font-size:small;padding-left:4px;} (Raymond Anton, Raymond F Anton, Ray Anton)

Publication Activity (10 Years)

Top Topics

Top Venues

Raymond K Anton (Raymond Anton, Raymond F Anton, Ray Anton)